APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor B

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vascular Endothelial Growth Factor B Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor B Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor B Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor B market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vascular Endothelial Growth Factor B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vascular Endothelial Growth Factor B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vascular Endothelial Growth Factor B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vascular Endothelial Growth Factor B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vascular Endothelial Growth Factor B include Eli Lilly and Company, Regeneron Pharmaceuticals Inc, Formycon AG, CSL Ltd and Alteogen Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vascular Endothelial Growth Factor B, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vascular Endothelial Growth Factor B, also provides the sales of main regions and countries. Of the upcoming market potential for Vascular Endothelial Growth Factor B, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vascular Endothelial Growth Factor B sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vascular Endothelial Growth Factor B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vascular Endothelial Growth Factor B sales, projected growth trends, production technology, application and end-user industry.

Vascular Endothelial Growth Factor B Segment by Company

Eli Lilly and Company

Regeneron Pharmaceuticals Inc

Formycon AG

CSL Ltd

Alteogen Inc

Vascular Endothelial Growth Factor B Segment by Type

CSL-346

Aflibercept

Aflibercept Biosimilar

Others

Vascular Endothelial Growth Factor B Segment by Application

Rectal Cancer

Diabetic Nephropathy

Retinal Vein Occlusion

Others

Vascular Endothelial Growth Factor B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vascular Endothelial Growth Factor B in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vascular Endothelial Growth Factor B manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vascular Endothelial Growth Factor B sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CSL-346 Major Manufacturers Table 3. Aflibercept Major Manufacturers Table 4. Aflibercept Biosimilar Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Rectal Cancer Major Manufacturers Table 8. Diabetic Nephropathy Major Manufacturers Table 9. Retinal Vein Occlusion Major Manufacturers Table 10. Others Major Manufacturers Table 11. Vascular Endothelial Growth Factor B Industry Trends Table 12. Vascular Endothelial Growth Factor B Industry Drivers Table 13. Vascular Endothelial Growth Factor B Industry Opportunities and Challenges Table 14. Vascular Endothelial Growth Factor B Industry Restraints Table 15. Global Vascular Endothelial Growth Factor B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Vascular Endothelial Growth Factor B Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Vascular Endothelial Growth Factor B Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2021-2026) Table 19. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2027-2032) Table 20. Global Vascular Endothelial Growth Factor B Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (k units) Table 22. Global Vascular Endothelial Growth Factor B Sales by Region (2027-2032) & (k units) Table 23. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2021-2026) Table 24. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2027-2032) Table 25. Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Vascular Endothelial Growth Factor B Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2021-2026) Table 29. Global Vascular Endothelial Growth Factor B Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Vascular Endothelial Growth Factor B Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Vascular Endothelial Growth Factor B Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Vascular Endothelial Growth Factor B Manufacturers, Product Type & Application Table 33. Global Vascular Endothelial Growth Factor B Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Vascular Endothelial Growth Factor B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Vascular Endothelial Growth Factor B Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2026) Table 40. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2027-2032) Table 41. Global Vascular Endothelial Growth Factor B Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 43. Global Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 44. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2026) Table 45. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2027-2032) Table 46. Global Vascular Endothelial Growth Factor B Price by Type (2021-2026) & (US$/unit) Table 47. Global Vascular Endothelial Growth Factor B Price by Type (2027-2032) & (US$/unit) Table 48. Global Vascular Endothelial Growth Factor B Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2026) Table 52. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2027-2032) Table 53. Global Vascular Endothelial Growth Factor B Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 55. Global Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 56. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2026) Table 57. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2027-2032) Table 58. Global Vascular Endothelial Growth Factor B Price by Application (2021-2026) & (US$/unit) Table 59. Global Vascular Endothelial Growth Factor B Price by Application (2027-2032) & (US$/unit) Table 60. Eli Lilly and Company Company Information Table 61. Eli Lilly and Company Business Overview Table 62. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio Table 64. Eli Lilly and Company Recent Development Table 65. Regeneron Pharmaceuticals Inc Company Information Table 66. Regeneron Pharmaceuticals Inc Business Overview Table 67. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio Table 69. Regeneron Pharmaceuticals Inc Recent Development Table 70. Formycon AG Company Information Table 71. Formycon AG Business Overview Table 72. Formycon AG Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Formycon AG Vascular Endothelial Growth Factor B Product Portfolio Table 74. Formycon AG Recent Development Table 75. CSL Ltd Company Information Table 76. CSL Ltd Business Overview Table 77. CSL Ltd Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio Table 79. CSL Ltd Recent Development Table 80. Alteogen Inc Company Information Table 81. Alteogen Inc Business Overview Table 82. Alteogen Inc Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio Table 84. Alteogen Inc Recent Development Table 85. North America Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 88. North America Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 89. North America Vascular Endothelial Growth Factor B Sales Price by Type (2021-2026) & (US$/unit) Table 90. North America Vascular Endothelial Growth Factor B Sales Price by Type (2027-2032) & (US$/unit) Table 91. North America Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 94. North America Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 95. North America Vascular Endothelial Growth Factor B Sales Price by Application (2021-2026) & (US$/unit) Table 96. North America Vascular Endothelial Growth Factor B Sales Price by Application (2027-2032) & (US$/unit) Table 97. North America Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. North America Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. North America Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 101. North America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 102. North America Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 103. North America Vascular Endothelial Growth Factor B Sales Price by Country (2021-2026) & (US$/unit) Table 104. North America Vascular Endothelial Growth Factor B Sales Price by Country (2027-2032) & (US$/unit) Table 105. United States Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 106. Canada Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 107. Mexico Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 108. Europe Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 111. Europe Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 112. Europe Vascular Endothelial Growth Factor B Sales Price by Type (2021-2026) & (US$/unit) Table 113. Europe Vascular Endothelial Growth Factor B Sales Price by Type (2027-2032) & (US$/unit) Table 114. Europe Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 117. Europe Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 118. Europe Vascular Endothelial Growth Factor B Sales Price by Application (2021-2026) & (US$/unit) Table 119. Europe Vascular Endothelial Growth Factor B Sales Price by Application (2027-2032) & (US$/unit) Table 120. Europe Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. Europe Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. Europe Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 124. Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 125. Europe Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 126. Europe Vascular Endothelial Growth Factor B Sales Price by Country (2021-2026) & (US$/unit) Table 127. Europe Vascular Endothelial Growth Factor B Sales Price by Country (2027-2032) & (US$/unit) Table 128. Germany Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 129. France Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 130. U.K. Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 131. Italy Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 132. Russia Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 133. Spain Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 135. Switzerland Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 136. Sweden Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 137. Poland Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 138. China Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 139. China Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 140. China Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 141. China Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 142. China Vascular Endothelial Growth Factor B Sales Price by Type (2021-2026) & (US$/unit) Table 143. China Vascular Endothelial Growth Factor B Sales Price by Type (2027-2032) & (US$/unit) Table 144. China Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 145. China Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 146. China Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 147. China Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 148. China Vascular Endothelial Growth Factor B Sales Price by Application (2021-2026) & (US$/unit) Table 149. China Vascular Endothelial Growth Factor B Sales Price by Application (2027-2032) & (US$/unit) Table 150. Asia Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 153. Asia Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 154. Asia Vascular Endothelial Growth Factor B Sales Price by Type (2021-2026) & (US$/unit) Table 155. Asia Vascular Endothelial Growth Factor B Sales Price by Type (2027-2032) & (US$/unit) Table 156. Asia Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 159. Asia Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 160. Asia Vascular Endothelial Growth Factor B Sales Price by Application (2021-2026) & (US$/unit) Table 161. Asia Vascular Endothelial Growth Factor B Sales Price by Application (2027-2032) & (US$/unit) Table 162. Asia Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Asia Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Asia Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 166. Asia Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 167. Asia Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 168. Asia Vascular Endothelial Growth Factor B Sales Price by Country (2021-2026) & (US$/unit) Table 169. Asia Vascular Endothelial Growth Factor B Sales Price by Country (2027-2032) & (US$/unit) Table 170. Japan Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 171. South Korea Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 172. India Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 173. Australia Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 174. Taiwan Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 175. Southeast Asia Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 176. SAMEA Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 179. SAMEA Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 180. SAMEA Vascular Endothelial Growth Factor B Sales Price by Type (2021-2026) & (US$/unit) Table 181. SAMEA Vascular Endothelial Growth Factor B Sales Price by Type (2027-2032) & (US$/unit) Table 182. SAMEA Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 183. SAMEA Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 184. SAMEA Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 185. SAMEA Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 186. SAMEA Vascular Endothelial Growth Factor B Sales Price by Application (2021-2026) & (US$/unit) Table 187. SAMEA Vascular Endothelial Growth Factor B Sales Price by Application (2027-2032) & (US$/unit) Table 188. SAMEA Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. SAMEA Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. SAMEA Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. SAMEA Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 192. SAMEA Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 193. SAMEA Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 194. SAMEA Vascular Endothelial Growth Factor B Sales Price by Country (2021-2026) & (US$/unit) Table 195. SAMEA Vascular Endothelial Growth Factor B Sales Price by Country (2027-2032) & (US$/unit) Table 196. Brazil Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 197. Argentina Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 198. Chile Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 199. Colombia Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 200. Peru Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 201. Saudi Arabia Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 202. Israel Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 203. UAE Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 204. Turkey Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 205. Iran Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 206. Egypt Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Vascular Endothelial Growth Factor B Distributors List Table 210. Vascular Endothelial Growth Factor B Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor B Image Figure 2. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Endothelial Growth Factor B Market Size Share 2021 VS 2025 VS 2032 Figure 4. CSL-346 Image Figure 5. Aflibercept Image Figure 6. Aflibercept Biosimilar Image Figure 7. Others Image Figure 8. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Vascular Endothelial Growth Factor B Market Size Share 2021 VS 2025 VS 2032 Figure 10. Rectal Cancer Image Figure 11. Diabetic Nephropathy Image Figure 12. Retinal Vein Occlusion Image Figure 13. Others Image Figure 14. Global Vascular Endothelial Growth Factor B Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Figure 16. Global Vascular Endothelial Growth Factor B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2021-2032) Figure 19. Global Vascular Endothelial Growth Factor B Sales (2021-2032) & (k units) Figure 20. Global Vascular Endothelial Growth Factor B Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Vascular Endothelial Growth Factor B Sales YoY (2021-2032) & (k units) Figure 23. Europe Vascular Endothelial Growth Factor B Sales YoY (2021-2032) & (k units) Figure 24. China Vascular Endothelial Growth Factor B Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Vascular Endothelial Growth Factor B Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales YoY (2021-2032) & (k units) Figure 27. Global Vascular Endothelial Growth Factor B Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Vascular Endothelial Growth Factor B Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Vascular Endothelial Growth Factor B Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2032) Figure 33. Global Vascular Endothelial Growth Factor B Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Vascular Endothelial Growth Factor B Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2032) Figure 36. Global Vascular Endothelial Growth Factor B Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2032) Figure 39. Global Vascular Endothelial Growth Factor B Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Vascular Endothelial Growth Factor B Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2032) Figure 42. North America Vascular Endothelial Growth Factor B Revenue Share by Type (2021-2032) Figure 43. North America Vascular Endothelial Growth Factor B Sales Share by Type (2021-2032) Figure 44. North America Vascular Endothelial Growth Factor B Revenue Share by Application (2021-2032) Figure 45. North America Vascular Endothelial Growth Factor B Sales Share by Application (2021-2032) Figure 46. North America Vascular Endothelial Growth Factor B Revenue Share by Country (2021-2032) Figure 47. North America Vascular Endothelial Growth Factor B Sales Share by Country (2021-2032) Figure 48. Europe Vascular Endothelial Growth Factor B Revenue Share by Type (2021-2032) Figure 49. Europe Vascular Endothelial Growth Factor B Sales Share by Type (2021-2032) Figure 50. Europe Vascular Endothelial Growth Factor B Revenue Share by Application (2021-2032) Figure 51. Europe Vascular Endothelial Growth Factor B Sales Share by Application (2021-2032) Figure 52. Europe Vascular Endothelial Growth Factor B Revenue Share by Country (2021-2032) Figure 53. Europe Vascular Endothelial Growth Factor B Sales Share by Country (2021-2032) Figure 54. China Vascular Endothelial Growth Factor B Revenue Share by Type (2021-2032) Figure 55. China Vascular Endothelial Growth Factor B Sales Share by Type (2021-2032) Figure 56. China Vascular Endothelial Growth Factor B Revenue Share by Application (2021-2032) Figure 57. China Vascular Endothelial Growth Factor B Sales Share by Application (2021-2032) Figure 58. Asia Vascular Endothelial Growth Factor B Revenue Share by Type (2021-2032) Figure 59. Asia Vascular Endothelial Growth Factor B Sales Share by Type (2021-2032) Figure 60. Asia Vascular Endothelial Growth Factor B Revenue Share by Application (2021-2032) Figure 61. Asia Vascular Endothelial Growth Factor B Sales Share by Application (2021-2032) Figure 62. Asia Vascular Endothelial Growth Factor B Revenue Share by Country (2021-2032) Figure 63. Asia Vascular Endothelial Growth Factor B Sales Share by Country (2021-2032) Figure 64. SAMEA Vascular Endothelial Growth Factor B Revenue Share by Type (2021-2032) Figure 65. SAMEA Vascular Endothelial Growth Factor B Sales Share by Type (2021-2032) Figure 66. SAMEA Vascular Endothelial Growth Factor B Revenue Share by Application (2021-2032) Figure 67. SAMEA Vascular Endothelial Growth Factor B Sales Share by Application (2021-2032) Figure 68. SAMEA Vascular Endothelial Growth Factor B Revenue Share by Country (2021-2032) Figure 69. SAMEA Vascular Endothelial Growth Factor B Sales Share by Country (2021-2032) Figure 70. Vascular Endothelial Growth Factor B Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Vascular Endothelial Growth Factor B Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • CSL-346
  • Aflibercept
  • Aflibercept Biosimilar
  • Others
Applications
  • Rectal Cancer
  • Diabetic Nephropathy
  • Retinal Vein Occlusion
  • Others
Companies covered
  • Eli Lilly and Company
  • Regeneron Pharmaceuticals Inc
  • Formycon AG
  • CSL Ltd
  • Alteogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vascular Endothelial Growth Factor B Market by Type
  3. 1.2.1 Global Vascular Endothelial Growth Factor B Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CSL-346
  5. 1.2.3 Aflibercept
  6. 1.2.4 Aflibercept Biosimilar
  7. 1.2.5 Others
  8. 1.3 Vascular Endothelial Growth Factor B Market by Application
  9. 1.3.1 Global Vascular Endothelial Growth Factor B Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Rectal Cancer
  11. 1.3.3 Diabetic Nephropathy
  12. 1.3.4 Retinal Vein Occlusion
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Vascular Endothelial Growth Factor B Market Dynamics
  1. 2.1 Vascular Endothelial Growth Factor B Industry Trends
  2. 2.2 Vascular Endothelial Growth Factor B Industry Drivers
  3. 2.3 Vascular Endothelial Growth Factor B Industry Opportunities and Challenges
  4. 2.4 Vascular Endothelial Growth Factor B Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vascular Endothelial Growth Factor B Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vascular Endothelial Growth Factor B Revenue by Region
  3. 3.2.1 Global Vascular Endothelial Growth Factor B Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vascular Endothelial Growth Factor B Revenue by Region (2021-2026)
  5. 3.2.3 Global Vascular Endothelial Growth Factor B Revenue by Region (2027-2032)
  6. 3.2.4 Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vascular Endothelial Growth Factor B Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vascular Endothelial Growth Factor B Sales by Region
  9. 3.4.1 Global Vascular Endothelial Growth Factor B Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026)
  11. 3.4.3 Global Vascular Endothelial Growth Factor B Sales by Region (2027-2032)
  12. 3.4.4 Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers
  2. 4.1.1 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vascular Endothelial Growth Factor B Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vascular Endothelial Growth Factor B Sales by Manufacturers
  6. 4.2.1 Global Vascular Endothelial Growth Factor B Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vascular Endothelial Growth Factor B Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vascular Endothelial Growth Factor B Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vascular Endothelial Growth Factor B Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vascular Endothelial Growth Factor B Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vascular Endothelial Growth Factor B Manufacturers, Product Type & Application
  13. 4.7 Global Vascular Endothelial Growth Factor B Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vascular Endothelial Growth Factor B Market CR5 and HHI
  16. 4.8.2 2025 Vascular Endothelial Growth Factor B Tier 1, Tier 2, and Tier 3
5 Vascular Endothelial Growth Factor B Market by Type
  1. 5.1 Global Vascular Endothelial Growth Factor B Revenue by Type
  2. 5.1.1 Global Vascular Endothelial Growth Factor B Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vascular Endothelial Growth Factor B Sales by Type
  6. 5.2.1 Global Vascular Endothelial Growth Factor B Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vascular Endothelial Growth Factor B Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vascular Endothelial Growth Factor B Price by Type
6 Vascular Endothelial Growth Factor B Market by Application
  1. 6.1 Global Vascular Endothelial Growth Factor B Revenue by Application
  2. 6.1.1 Global Vascular Endothelial Growth Factor B Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vascular Endothelial Growth Factor B Sales by Application
  6. 6.2.1 Global Vascular Endothelial Growth Factor B Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vascular Endothelial Growth Factor B Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vascular Endothelial Growth Factor B Price by Application
7 Company Profiles
  1. 7.1 Eli Lilly and Company
  2. 7.1.1 Eli Lilly and Company Company Information
  3. 7.1.2 Eli Lilly and Company Business Overview
  4. 7.1.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio
  6. 7.1.5 Eli Lilly and Company Recent Developments
  7. 7.2 Regeneron Pharmaceuticals Inc
  8. 7.2.1 Regeneron Pharmaceuticals Inc Company Information
  9. 7.2.2 Regeneron Pharmaceuticals Inc Business Overview
  10. 7.2.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio
  12. 7.2.5 Regeneron Pharmaceuticals Inc Recent Developments
  13. 7.3 Formycon AG
  14. 7.3.1 Formycon AG Company Information
  15. 7.3.2 Formycon AG Business Overview
  16. 7.3.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Formycon AG Vascular Endothelial Growth Factor B Product Portfolio
  18. 7.3.5 Formycon AG Recent Developments
  19. 7.4 CSL Ltd
  20. 7.4.1 CSL Ltd Company Information
  21. 7.4.2 CSL Ltd Business Overview
  22. 7.4.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio
  24. 7.4.5 CSL Ltd Recent Developments
  25. 7.5 Alteogen Inc
  26. 7.5.1 Alteogen Inc Company Information
  27. 7.5.2 Alteogen Inc Business Overview
  28. 7.5.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio
  30. 7.5.5 Alteogen Inc Recent Developments
8 North America
  1. 8.1 North America Vascular Endothelial Growth Factor B Market Size by Type
  2. 8.1.1 North America Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  3. 8.1.2 North America Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  4. 8.1.3 North America Vascular Endothelial Growth Factor B Price by Type (2021-2032)
  5. 8.2 North America Vascular Endothelial Growth Factor B Market Size by Application
  6. 8.2.1 North America Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  7. 8.2.2 North America Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  8. 8.2.3 North America Vascular Endothelial Growth Factor B Price by Application (2021-2032)
  9. 8.3 North America Vascular Endothelial Growth Factor B Market Size by Country
  10. 8.3.1 North America Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vascular Endothelial Growth Factor B Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Vascular Endothelial Growth Factor B Market Size by Type
  2. 9.1.1 Europe Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  4. 9.1.3 Europe Vascular Endothelial Growth Factor B Price by Type (2021-2032)
  5. 9.2 Europe Vascular Endothelial Growth Factor B Market Size by Application
  6. 9.2.1 Europe Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  8. 9.2.3 Europe Vascular Endothelial Growth Factor B Price by Application (2021-2032)
  9. 9.3 Europe Vascular Endothelial Growth Factor B Market Size by Country
  10. 9.3.1 Europe Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vascular Endothelial Growth Factor B Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Vascular Endothelial Growth Factor B Market Size by Type
  2. 10.1.1 China Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  3. 10.1.2 China Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  4. 10.1.3 China Vascular Endothelial Growth Factor B Price by Type (2021-2032)
  5. 10.2 China Vascular Endothelial Growth Factor B Market Size by Application
  6. 10.2.1 China Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  7. 10.2.2 China Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  8. 10.2.3 China Vascular Endothelial Growth Factor B Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vascular Endothelial Growth Factor B Market Size by Type
  2. 11.1.1 Asia Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  4. 11.1.3 Asia Vascular Endothelial Growth Factor B Price by Type (2021-2032)
  5. 11.2 Asia Vascular Endothelial Growth Factor B Market Size by Application
  6. 11.2.1 Asia Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  8. 11.2.3 Asia Vascular Endothelial Growth Factor B Price by Application (2021-2032)
  9. 11.3 Asia Vascular Endothelial Growth Factor B Market Size by Country
  10. 11.3.1 Asia Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vascular Endothelial Growth Factor B Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vascular Endothelial Growth Factor B Market Size by Type
  2. 12.1.1 SAMEA Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vascular Endothelial Growth Factor B Price by Type (2021-2032)
  5. 12.2 SAMEA Vascular Endothelial Growth Factor B Market Size by Application
  6. 12.2.1 SAMEA Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vascular Endothelial Growth Factor B Price by Application (2021-2032)
  9. 12.3 SAMEA Vascular Endothelial Growth Factor B Market Size by Country
  10. 12.3.1 SAMEA Vascular Endothelial Growth Factor B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vascular Endothelial Growth Factor B Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vascular Endothelial Growth Factor B Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vascular Endothelial Growth Factor B Value Chain Analysis
  2. 13.1.1 Vascular Endothelial Growth Factor B Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vascular Endothelial Growth Factor B Production Mode & Process
  6. 13.2 Vascular Endothelial Growth Factor B Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vascular Endothelial Growth Factor B Distributors
  9. 13.2.3 Vascular Endothelial Growth Factor B Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst